We are live on ! Find out more
CF

Corebridge Financial Portfolio holdings

AUM $4.25M
1-Year Est. Return 33.15%
This Fund
S&P 500
This Quarter Est. Return
+4.52%
1 Year Est. Return
-33.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$18.5B
AUM Growth
-$232M
Cap. Flow
-$540M
Cap. Flow %
-2.92%
Top 10 Hldgs %
27.76%
Holding
3,069
New
24
Increased
234
Reduced
2,759
Closed
38

Top Buys

Rank Stock Value
1
EFA icon
iShares MSCI EAFE ETF
EFA
+$41.7M
2
DOCU
DocuSign
DOCU
+$18.2M
3
APO icon
Apollo Global Management
APO
+$17.5M
4
FLEX icon
Flex
FLEX
+$16.1M
5
WDAY icon
Workday
WDAY
+$12.9M

Sector Composition

Rank Sector Weight
1 Technology 29.77%
2 Financials 13.35%
3 Consumer Discretionary 11.87%
4 Industrials 10.17%
5 Healthcare 10%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSTM icon
1526
Constellium
CSTM
$3.55B
$661K ﹤0.01%
64,388
-4,860
-7% -$59.8K
INFN
1527
DELISTED
Infinera Corporation Common Stock
INFN
$661K ﹤0.01%
100,637
-7,596
-7% -$50.6K
KGS icon
1528
Kodiak Gas Services
KGS
$6.46B
$661K ﹤0.01%
16,186
+5,409
+50% +$196K
OCUL icon
1529
Ocular Therapeutix
OCUL
$2.3B
$661K ﹤0.01%
77,362
-5,840
-7% -$57K
APPN icon
1530
Appian
APPN
$2.49B
$660K ﹤0.01%
20,025
-1,512
-7% -$54K
PRAX icon
1531
Praxis Precision Medicines
PRAX
$9.34B
$660K ﹤0.01%
8,574
-646
-7% -$46.7K
AMWD
1532
DELISTED
American Woodmark
AMWD
$660K ﹤0.01%
8,296
-651
-7% -$59.6K
COHU icon
1533
Cohu
COHU
$2.7B
$658K ﹤0.01%
24,657
-1,938
-7% -$50.7K
NRIX icon
1534
Nurix Therapeutics
NRIX
$2.6B
$658K ﹤0.01%
34,907
+770
+2% +$17.6K
QCRH icon
1535
QCR Holdings
QCRH
$1.68B
$657K ﹤0.01%
8,144
-615
-7% -$51.7K
TVTX icon
1536
Travere Therapeutics
TVTX
$6.24B
$654K ﹤0.01%
37,565
-1,832
-5% -$32.4K
THRM icon
1537
Gentherm
THRM
$1.19B
$654K ﹤0.01%
16,389
-1,646
-9% -$69K
TWO
1538
DELISTED
Two Harbors Investment
TWO
$654K ﹤0.01%
55,280
-4,316
-7% -$52.2K
MYGN icon
1539
Myriad Genetics
MYGN
$327M
$654K ﹤0.01%
47,667
-3,716
-7% -$68.6K
BBT
1540
Beacon Financial Corp
BBT
$2.63B
$649K ﹤0.01%
22,833
-1,783
-7% -$51.4K
EVH icon
1541
Evolent Health
EVH
$474M
$646K ﹤0.01%
57,395
-4,332
-7% -$76.1K
SAFT icon
1542
Safety Insurance
SAFT
$1.52B
$645K ﹤0.01%
7,822
-611
-7% -$50.6K
STAA icon
1543
STAAR Surgical
STAA
$1.14B
$640K ﹤0.01%
26,335
-2,052
-7% -$58.6K
RVLV icon
1544
Revolve Group
RVLV
$1.5B
$639K ﹤0.01%
19,074
-1,439
-7% -$44.6K
EMBC icon
1545
Embecta
EMBC
$280M
$637K ﹤0.01%
30,855
-2,408
-7% -$39.5K
ARI
1546
Apollo Commercial Real Estate
ARI
$852M
$635K ﹤0.01%
73,372
-7,856
-10% -$70.6K
LADR
1547
Ladder Capital
LADR
$1.22B
$632K ﹤0.01%
56,440
-4,260
-7% -$48.9K
KLG
1548
DELISTED
WK Kellogg Co
KLG
$629K ﹤0.01%
34,957
-2,722
-7% -$49.8K
AIV
1549
Aimco
AIV
$349M
$629K ﹤0.01%
69,159
-6,903
-9% -$59.6K
PCT icon
1550
PureCycle Technologies
PCT
$1.21B
$628K ﹤0.01%
61,290
-4,626
-7% -$53.7K

Similar funds

Corebridge Financial's Q4 2024 Portfolio in Review

As of Q4 2024, Corebridge Financial held 3,069 positions worth $18.5B, down 1.2% from $18.7B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Trading was light in Q4 2024: portfolio turnover was 2%. Corebridge Financial opened 24 new positions and exited 38, leaving the 3,069-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Corebridge Financial's largest Q4 2024 buy was Apollo Global Management: 110,177 shares worth $18.2M.
  • Corebridge Financial added most to iShares MSCI EAFE ETF in Q4 2024, an estimated $41.7M increase.
  • Corebridge Financial's biggest Q4 2024 reduction was Apple, cutting an estimated $36.8M.
  • Corebridge Financial fully exited Southwestern Energy Company in Q4 2024, selling an estimated $9.27M.
  • Corebridge Financial's ten largest holdings make up 28% of its $18.5B portfolio in Q4 2024.
  • Corebridge Financial opened 24 new positions and closed 38 in Q4 2024.
  • Corebridge Financial's portfolio value fell 1.2% quarter-over-quarter to $18.5B.

Based on Corebridge Financial's 13F filing for Q4 2024, filed 11 Feb 2025.